Skip to content
  • Grants
    • International Grants
    • US Grants
  • Tools
    • Patient Registry
  • Archive
    • Case Studies
    • GPRO
      • List of HBV Access Countries
      • List of HCV Access Countries
    • Reports
    • UHEP
      • Overview
      • Coalition of Partners
      • Project Team
      • Innovations and Optimizations
      • Methodology
      • Disease Burden and Financials
      • UHEP Data – March 2020
      • UHEP Data – Final
    • US State Analyses
      • States Dashboard
      • States Compare
      • States Maps
      • States Distribution
      • Donors
  • Contact
  • Donate
  • Privacy Statement
  • CDA Foundation
  • CDAF
    • Overview
    • Board of Directors
    • Corporate Documents
    • Our Team
    • Publications
    • In the News
    • Conference Proceedings
  • Polaris
    • Overview
    • Dashboard
    • Compare
    • Elimination Maps
    • Global Distribution
    • Database Query
    • FAQ
    • Training
    • Donors
    • Collaborator Portal
  • Relink
    • Overview
    • FAQ
    • Request for Proposal
    • Grantees
    • Hep-CARE
    • Resources
  • CDAF
    • Overview
    • Board of Directors
    • Corporate Documents
    • Our Team
    • Publications
    • In the News
    • Conference Proceedings
  • Polaris
    • Overview
    • Dashboard
    • Compare
    • Elimination Maps
    • Global Distribution
    • Database Query
    • FAQ
    • Training
    • Donors
    • Collaborator Portal
  • Relink
    • Overview
    • FAQ
    • Request for Proposal
    • Grantees
    • Hep-CARE
    • Resources
  • Grants
    • International Grants
    • US Grants
  • Tools
    • Patient Registry
  • Archive
    • Case Studies
    • GPRO
      • List of HBV Access Countries
      • List of HCV Access Countries
    • Reports
    • UHEP
      • Overview
      • Coalition of Partners
      • Project Team
      • Innovations and Optimizations
      • Methodology
      • Disease Burden and Financials
      • UHEP Data – March 2020
      • UHEP Data – Final
    • US State Analyses
      • States Dashboard
      • States Compare
      • States Maps
      • States Distribution
      • Donors
  • Contact
  • Donate
  • Privacy Statement
  • Conference Proceedings

    July 8, 2022

    Evaluation of Global Progress Towards HBV and HCV Elimination

    Read More
    July 8, 2022

    The Impact of Vaccination on the Global and Regional Paediatric Prevalence of Hepatitis B from 1985–2022

    Read More
    July 6, 2022

    The Elimination of Hepatitis C in the Cherokee Nation: The Impact of Harm Reduction

    Read More
    June 27, 2022

    Economic Investment and Strategies to Eliminate Chronic Hepatitis C in Mexico

    Read More
    June 26, 2022

    Hepatitis C Prevalence and Elimination Planning in Pakistan, a Bottom-Up Approach

    Read More
    June 25, 2022

    Catalytic Funding and Netflix Model to Finance Viral Hepatitis Elimination

    Read More
    June 24, 2022

    The Disease Burden of Hepatitis B and C from 2015–2030: The Long and Winding Road Towards Elimination

    Read More
    June 23, 2022

    The Incidence of Chronic HBV by Age, 2022

    Read More
    June 22, 2022

    Updated Evaluation of Global Progress Towards HBV and HCV Elimination, Preliminary Data Through 2021

    Read More
    June 21, 2022

    Population Adjusted Prevalence of Hepatitis Delta Virus in 16 Countries and Territories

    Read More
    November 22, 2021

    Modeling disease burden of nonalcoholic fatty liver disease (NAFLD) in Japan

    Read More
    November 22, 2021

    Simplified test and treat protocols for population level screening and elimination of hepatitis B and hepatitis C in Uzbekistan

    Read More
    November 22, 2021

    Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress

    Read More
    November 22, 2021

    Cost-Effectiveness Analysis of Treating All HBsAg+ Individuals in the United States

    Read More
    November 22, 2021

    Global HBV Cascade of Care: The Pre-COVID-19 Baseline

    Read More
    November 18, 2021

    The global non-alcoholic fatty liver disease (NAFLD) preparedness index: Are countries ready to tackle the challenge?

    Read More
    November 18, 2021

    Simplified test & treat protocols to eliminate HCV & HBV in Uzbekistan

    Read More
    November 18, 2021

    The impact of expanding antiviral treatment criteria at a population level in the Republic of Korea: A modeling analysis

    Read More
    November 22, 2020

    The Hep-CORE Policy Score: A European hepatitis C national policy implementation ranking

    Read More
    November 22, 2020

    Do countries have the right policies to eliminate viral hepatitis B and C: a secondary analysis of the Lancet GastroHep Viral Hepatitis Commission

    Read More
    November 22, 2020

    Anticipated timing of elimination of hepatitis C virus in Canada’s four most populous provinces

    Read More
    November 22, 2020

    Global timing of hepatitis C virus elimination in high-income countries: an updated analysis

    Read More
    November 22, 2020

    Catalytic funding for viral hepatitis elimination program in Uzbekistan

    Read More
    November 22, 2020

    Global prevalence of hepatitis C virus in women of childbearing age in 2019: A modeling study

    Read More
    November 22, 2020

    NAFLD Disease Burden – Canada, 2019-2030

    Read More
    November 22, 2019

    Modeling NAFLD-Related Disease Progression among the PITER SVR12 Cohort

    Read More
    November 22, 2019

    Screening strategies for hepatitis C virus elimination in Italy

    Read More
    November 22, 2019

    The Consensus Hepatitis C Cascade of Care: Methodology and initial findings from three countries

    Read More
    November 22, 2019

    Achieving accelerated elimination of hepatitis C virus infection by 2025: a case study in France

    Read More
    November 22, 2019

    Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets

    Read More
    November 22, 2019

    Eliminating Hepatitis C in Portugal: Treatment and Diagnosis Requirements for Two Timelines

    Read More
    November 22, 2018

    The Disease Burden of Hepatitis B in Republic of Uzbekistan: Strategies Providing Hope for the Future

    Read More
    November 22, 2018

    Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Targets for Hepatitis C in the South East Asia Region

    Read More
    November 22, 2018

    Hepatitis C Infection in the Eastern Mediterranean Region: The Current Burden of Disease and a Road Map for Achieving the WHO Global Health Sector Strategy Targets

    Read More
    November 22, 2018

    Eliminating Hepatitis C Virus (HCV) in Indonesia

    Read More
    November 22, 2018

    Disease Burden of Hepatitis B in the Kyrgyz Republic: A Focus on Prevention

    Read More
    November 22, 2018

    Achieving the World Health Organization Global Health Sector Strategies for Hepatitis C in the WHO Western Pacific Region: A Modelling Study

    Read More
    November 22, 2018

    The Global Prevalence of HBsAg by Age in 2016 and the Case for Universal Treatment in Low and Middle Income Countries

    Read More
    November 22, 2018

    The current and future disease burden of hepatitis B virus in the general population and among five-year-olds in the Eastern Mediterranean Region

    Read More
    November 22, 2018

    Quantifying the impact of achieving the World Health Organization global health sector strategy goals for hepatitis C in the EURO region

    Read More
    November 22, 2018

    Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Goals for Hepatitis C in the AFRO Region

    Read More
    November 22, 2018

    Micro-Elimination of Chronic Hepatitis C in Switzerland: Modelling the Swiss Hepatitis Strategy Goals in Urban and Rural Regions

    Read More
    November 22, 2018

    Impact of the Hepatitis B Vaccine Birth-Dose on Perinatal Incidence between 2017-2050: Results from 17 WHO AFRO Countries

    Read More
    November 22, 2018

    Hepatitis C infection in the Pan American Health Organization Region: The current burden of disease and a road map for achieving the World Health Organization Global Health Sector Strategy Goals

    Read More
    November 22, 2018

    Forecasting liver disease burden based on a real life cohort of linked-to-care patients in Italy. Does the “hidden portion of the iceberg” matter to reach the WHO HCV elimination goals in high HCV prevalent countries?

    Read More
    November 22, 2018

    Achieving World Health Organization Targets for Hepatitis B in Infants and 5-year-olds by 2030: Results from 17 WHO AFRO Countries

    Read More
    November 22, 2018

    Achieving World Health Organization Targets for Hepatitis B by 2030: Results from 17 WHO AFRO Countries

    Read More
    November 22, 2018

    Estimates and projection of disease burden and economic analysis for hepatitis C in Viet Nam

    Read More
    November 22, 2018

    Estimates and projection of disease burden and economic analysis for hepatitis B in Viet Nam

    Read More
    November 22, 2018

    Global Cascade of Care for HBV and HCV

    Read More
    November 22, 2018

    Should changing epidemiology change HAV vaccination policy?

    Read More
    November 22, 2018

    Elimination of Hepatitis C in Brazil is Cost-Saving – courtesy of Ministry of Health, Brasilia, Brazil

    Read More
    November 22, 2018

    The value proposition of NASH therapy on the burden of disease related to obesity

    Read More

    1120 W South Boulder Rd
    Suite 102
    Lafayette, CO 80026


    • Phone: 720.890.4848
    • Fax: 720.890.3817
    • Email: info@cdafound.org

    Useful Links, CDAF

    • Overview
    • Board of Directors
    • Publications
    • Conference Proceedings

    Useful Links, Polaris

    • Overview
    • FAQ
    • Training
    • Collaborator Portal

    Latest News

    Center for Disease Analysis Foundation Awards Second Round of Grants for the CDAF-Relink Program

    July 30, 2024

    Read More

    Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant

    March 18, 2024

    Read More
    USFCR Verified Vendor

    Copyright ©2025 CDA Foundation

    Copyright ©2025 CDA Foundation

    en_USEnglish
    es_MXSpanish fr_FRFrench ru_RURussian arArabic en_USEnglish
    Manage Cookie Consent
    We use cookies to optimize our website and our service.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Preferences
    {title} {title} {title}